While the role of PAF-receptor (PAF-R) has been implicated in mediating chemotherapy effects, its significance in chemotherapy-mediated MVP release in pancreatic cancer has not been studied. The gene discussed is PTAFR; the disease is familial pancreatic carcinoma.